The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
2.850
0.00 (0.00%)
Mar 5, 2026, 4:00 PM EST - Market closed
The Oncology Institute Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for The Oncology Institute stock have an average target of 6.00, with a low estimate of 5.00 and a high estimate of 7.00. The average target predicts an increase of 110.53% from the current stock price of 2.85.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 25, 2025.
Analyst Ratings
The average analyst rating for The Oncology Institute stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +75.44% | Nov 25, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +145.61% | Oct 21, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +110.53% | Jul 16, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $2.5 | Strong Buy | Initiates | $2.5 | -12.28% | Feb 26, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $3 → $2 | Strong Buy | Maintains | $3 → $2 | -29.82% | Jun 16, 2023 |
Financial Forecast
Revenue This Year
505.58M
from 393.41M
Increased by 28.51%
Revenue Next Year
642.53M
from 505.58M
Increased by 27.09%
EPS This Year
-0.59
from -0.71
EPS Next Year
-0.30
from -0.59
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 528.4M | 693.2M | |
| Avg | 505.6M | 642.5M | |
| Low | 488.0M | 591.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 34.3% | 37.1% | |
| Avg | 28.5% | 27.1% | |
| Low | 24.1% | 17.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.57 | -0.18 | |
| Avg | -0.59 | -0.30 | |
| Low | -0.62 | -0.43 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.